These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 6848289)

  • 1. Pharmacotherapy for behavior disorders. Typical treatment practices.
    Gadow KD
    Clin Pediatr (Phila); 1983 Jan; 22(1):48-53. PubMed ID: 6848289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
    Foy JM; Earls MF
    Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulant medication use by primary care physicians in the treatment of attention deficit hyperactivity disorder.
    Wolraich ML; Lindgren S; Stromquist A; Milich R; Davis C; Watson D
    Pediatrics; 1990 Jul; 86(1):95-101. PubMed ID: 2359688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attention-deficit disorder. A paradigm for psychotropic medication intervention in pediatrics.
    Block SL
    Pediatr Clin North Am; 1998 Oct; 45(5):1053-83. PubMed ID: 9884675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can the physician diagnose hyperactivity in the office?
    Sleator EK; Ullmann RK
    Pediatrics; 1981 Jan; 67(1):13-7. PubMed ID: 7243422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Period prevalence of concomitant psychotropic medication usage among children and adolescents with attention-deficit/hyperactivity disorder during 2009.
    Betts KA; Sikirica V; Hodgkins P; Zhou Z; Xie J; DeLeon A; Erder MH; Wu EQ
    J Child Adolesc Psychopharmacol; 2014 Jun; 24(5):260-8. PubMed ID: 24839998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parents report on stimulant-treated children in the Netherlands: initiation of treatment and follow-up care.
    Faber A; Kalverdijk LJ; de Jong-van den Berg LT; Hugtenburg JG; Minderaa RB; Tobi H
    J Child Adolesc Psychopharmacol; 2006 Aug; 16(4):432-40. PubMed ID: 16958568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylphenidate treatment in children with borderline IQ and mental retardation: analysis of three aggregated studies.
    Aman MG; Buican B; Arnold LE
    J Child Adolesc Psychopharmacol; 2003; 13(1):29-40. PubMed ID: 12804124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized controlled double-blind trial of optimal dose methylphenidate in children and adolescents with severe attention deficit hyperactivity disorder and intellectual disability.
    Simonoff E; Taylor E; Baird G; Bernard S; Chadwick O; Liang H; Whitwell S; Riemer K; Sharma K; Sharma SP; Wood N; Kelly J; Golaszewski A; Kennedy J; Rodney L; West N; Walwyn R; Jichi F
    J Child Psychol Psychiatry; 2013 May; 54(5):527-35. PubMed ID: 22676856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double-blind administration of methylphenidate to mentally retarded children with attention deficit disorder; a preliminary study.
    Varley CK; Trupin EW
    Am J Ment Defic; 1982 May; 86(6):560-6. PubMed ID: 7102728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Autonomy attitudes in the treatment compliance of a cohort of subjects with continuous psychotropic drug administration].
    Baumann M; Trincard M
    Encephale; 2002; 28(5 Pt 1):389-96. PubMed ID: 12386539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychotropic drug utilization in children with concurrent attention-deficit/hyperactivity disorder and anxiety.
    Liu X; Kubilis P; Xu D; Bussing R; Winterstein AG
    J Anxiety Disord; 2014 Aug; 28(6):530-6. PubMed ID: 24981018
    [No Abstract]   [Full Text] [Related]  

  • 13. The ethics of informed parental consent to psychiatric drugging of children.
    Breeding J; Baughman F
    Ethical Hum Sci Serv; 2001; 3(3):175-88. PubMed ID: 15278979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An overview of three decades of research in pediatric psychopharmacoepidemiology.
    Gadow KD
    J Child Adolesc Psychopharmacol; 1997; 7(4):219-36. PubMed ID: 9542694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary school teachers' attitudes about children with attention deficit/hyperactivity disorder and the role of pharmacological treatment.
    Moldavsky M; Pass S; Sayal K
    Clin Child Psychol Psychiatry; 2014 Apr; 19(2):202-16. PubMed ID: 23625952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of methylphenidate among preschool children with developmental disabilities and ADHD.
    Handen BL; Feldman HM; Lurier A; Murray PJ
    J Am Acad Child Adolesc Psychiatry; 1999 Jul; 38(7):805-12. PubMed ID: 10405497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review of pharmacotherapy options for the treatment of attention-deficit/hyperactivity disorder (ADHD) and ADHD-like symptoms in children and adolescents with developmental disorders.
    Rowles BM; Findling RL
    Dev Disabil Res Rev; 2010; 16(3):273-82. PubMed ID: 20981766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fenfluramine and methylphenidate in children with mental retardation and borderline IQ: clinical effects.
    Aman MG; Kern RA; Osborne P; Tumuluru R; Rojahn J; del Medico V
    Am J Ment Retard; 1997 Mar; 101(5):521-34. PubMed ID: 9083608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacotherapy of attention deficit hyperactivity disorder.
    Spencer T; Biederman J; Wilens T
    Child Adolesc Psychiatr Clin N Am; 2000 Jan; 9(1):77-97. PubMed ID: 10674191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parental angst making and revisiting decisions about treatment of attention-deficit/hyperactivity disorder.
    Brinkman WB; Sherman SN; Zmitrovich AR; Visscher MO; Crosby LE; Phelan KJ; Donovan EF
    Pediatrics; 2009 Aug; 124(2):580-9. PubMed ID: 19651580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.